Studies were conducted to determine if in vivo exposure to dinitrotoluenes (DNT), which is associated with circulatory disorders of atherosclerotic etiology in humans, is associated with alterations of vascular smooth muscle cells (SMC) consistent with the atherogenic process. Sprague-Dawley rats (150-180 g) were injected IP for 5 days/week for 8 weeks with 2,4- or 2,6-DNT (0.5, 5, or 10 mg/kg) or medium chain triglyceride (MCT) oil. Histopathologic evaluation of aortae from animals exposed to either isomer showed dysplasia and rearrangement of SMC at all doses tested. Reduced 3H-thymidine incorporation was observed in primary cultures of aortic SMC from DNT-exposed animals relative to vehicle controls. This inhibitory response was maintained for up to two passages in culture after which a significant increase in thymidine incorporation was observed. Exposure of SMC from naive animals to DNT in vitro (1–100 µM) did not alter the extent of thymidine incorporation in cycling or growth-arrested cultures. In contrast, exposure to 2,4- or 2,6-diaminotoluene (DAT) (1–100 µM), carcinogens which share toxic metabolic intermediates in common with DNT, inhibited replicative DNA synthesis and stimulated unscheduled DNA synthesis in cycling and growth-arrested cultures of SMC, respectively. Our results suggest that modulation of DNA synthesis in aortic SMC by DNT metabolites generated in vivo contribute to the development of vascular lesions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- DAT:
-
diaminotuluene
- tDNT:
-
technical grade dinitrotoluene
- DNT:
-
dinitrotoluenes
- HU:
-
hydroxyurea
- IP:
-
intraperitoneal
- LDH:
-
lactate dehydrogenase
- MCT oil:
-
medium chain triglyceride
- NPTC:
-
non-protein thiol content
- RDS:
-
replicative DNA synthesis
- SEM:
-
standard error of the mean
- SMC:
-
smooth muscle cells
- UDS:
-
unscheduled DNA synthesis
References
ALBERTS, R.E., VANDERLAAN, M., BURNS, F.J. and NISHIZUMI, M. (1977). “Effect of carcinogens on chicken atherosclerosis”. Cancer Res. 37:2232–2235.
AMES, B.N., KAMMEN, H.O., and YAMASAKI, E. (1975). “Hair dyes are mutagenic: Identification of a variety of mutagenic ingredients.” Proc. Natl. Acad. Sci. USA. 72:2423–2427.
BENDITT, E.P. and BENDITT, J.M. (1973).“Evidence for monoclonal origin of human atherosclerotic plaques.” Proc. Natl. Acad. Sci. USA. 70:1753–1756.
BERMUDEZ, E., TILLERY, D., and BUTTERWORTH, B.E. (1979). “The effect of 2,4-diaminotoluene and isomers of dinitrotoluene on unscheduled DNA synthesis in primary rat hepatocytes.” Envir. Mutag. 1:391–398.
BOND, J.A., YANG, H-Y.L., MAJESKY, M.W., BENDITT, E.P., and JUCHAU, M.R. (1980). “Metabolism of benzo[a]pyrenen and 7,12 dimethylbanz[a]anthracene in chicken aortas: Monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro.” Tox. Appl. Pharmacol. 52:323–335.
CHEMICAL INDUSTRY INSTITUTE OF TOXICOLOGY (1982). “104 Week chronic toxicity study in rats. Dinitrotoluene.” Final Report. Docket # 12362.
COX, L.R. and RAMOS, K. (1990). “Allylmaine-induced phenotypic modulation of aortic smooth muscle cells.” J. Exp. Pathol. 71:11–18.
DENT, J.G., SCHNELL, s.R., and GUEST, D. (1981). “Metabolism of 2,4-dinitrotuluene in rat hepatic microsomes and cecal flora.” In: Proceedings of the Second International Symposium on Biologically Reactive Intermediates: Chemical Mechanisms and Biologic Effects. Plenum, New York, pp. 431–436.
ELLIS, H.V. II HOUGH, C.B., DACRE, Y.C. and LEE, C.C. (1978).“Chronic toxicity of 2,4-dinitrotoluene in the rat.” Toxicol. Appl. Pharmacol. {vn45}:245.
FURIHATA, C. and MATSUHIMA, T. (1987). “Use of in vivo/in vitro unscheduled DNA synthesis for identification of organ-specific carcinogens.” CRC Crit. Rev. Tox. 17:245–277.
GRUNWALD, J., FINGERLE, J., HAMMERLE, H., BETZ, E., and HAUDENSCHILD, C.C. (1987). “Cytocontractile structures and proteins of smooth muscle cells during the formation of experimental lesions.” Exp.. Mol. Pathol. 46:78–88.
HOLBROOK, D.J. (1980). “Effects of toxicants on nucleic and protein metabolism.” In: Introduction to Biochemical Toxicology. (Hodgson, E. and Guthrei, F.E., eds.) Elsevier, New York, pp. 268–269.
ITO, N., HIASA, Y., KONISHI, Y., and MARUGAMI, M. (1969). “The development of in liver of rats treated with m-toluylene diamine and the synergistic and antagonistic effects with other chemicals.” Cancer Rex. 29: 1137–1145.
JOKINEN, M.P., CLARKSON, T.B., and PRICHARD, r.W. (1985). “Recent advances in molecular pathology. Animal models in atherosclerosis research.” Exp. Mol. Pathol. 42:1–28.
LEONARD, T.B., LYGHT, O. and POPP J.A. (1983). “dinitrotuluene structure-dependent initiation of hepatocytes in vivo.” Carcinogenesis 4:1059–1061.
LEONARD, T.B., GRAICHEN, M.E., and POPP, J.A. (1987). “dinitrotuluene isomer-specific hepatocarconogenesosom F344 Rats.” J. Natl. Cancer Inst. 79:1313–1319.
LEVINE, R.J., ANDJELKOVICH, D.A., KERSTETER, S.L., ARP, E.A., BALOGH, S.A., BLUNDEN, P.B., and STANLEY, J.M. (1986). “Heart disease in workers exposed to dinitrotoluene.” J. Occup. Med. 28:811–816.
LEVINE, R.J. (1987). “dinitrotuluene: Human atherogen, carcinogen, neither or both?” CIIT Activities 7: 1–5.
LONG, R.M. and RICKERT, D.E (1982). “Metabolism and excretion of 2,6-dinitro[14C]toluene in vivo and in isolated perfused rat livers.” Drug Metab. Disp. 10455–458.
MAJESKY, M.W., REIDY, M.A., BENDITT, E.P., and JUCHAU, M.R. (1985). “Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence.” Proc. Natl. Acad. Sci. USA. 82: 3450–3454.
McGEE, L.C., McCAUSLAND, A., and PLUME, C.A. (1942). “Metabolic disturbances in workers exposed to dinitrotoluene.” Am. J. Dig. Dis. 9:329–332.
MIRSALIS, J. and BUTTERWORTH, B.E. (1982). “Induction of unscheduled DNA synthesis in rat hepatocytes following in vivo treatment with dinitrotoluene.” Carcinogenesis 3:241–29.
MIRSALIS, J.C., HAMM, T.E., SHERRILL, J.M., and BUTTERWORTH, B.E. (1982). “Role of gut flora in the genetoxicity of dinitrotoluene.” Nature 295:322–323.
MITCHELL, D.B., SANTONE, K.S., and ACOSTA, D. (1980). “Evaluation of cytotoxicity in cultured cells by enzyme leakage.” J. Tiss. Cult. Methods 6:113–116.
MOSS, N. and BENDITT, E.P. (1970). “The ultrastructure of spontaneous and experimentally-induced arterial lesions. II. Spontaneous plaques in chickens.” Lab. Inv. 23231–245.
NILSSON, J. (1986). “Growth factors and thel pathogenesis of atherosclerosis.” Atherosclerosis 62: 185–199.
RAMOS, K. and COX, L.X. (1987). “Primary cultures of rat aortic endothelial and smooth muscle cells: An in vitro model to study xenobiotic-induced vascular cytotoxicity.” In Vitro Cell. Dev. Biol. 23288–296.
RAMOS, K., COMBS, A.B., and ACOSTA, D. (1983). “Cytotoxicity of isoproterenol to cultured heart cells: Effects of antioxidants on modifying membrane damage.” Toxicol. Appl. Pharmacol. 70:317–323.
RICKERT, D.E., LONG, R.M., KRAKOWKA, S., and DENT, J.G. (1981). “Metabolism and excretion of 2,4-[14C]dinitrotoluene in conventional and axenic Fisher-344 rats.” Toxicol. Appl. Pharmacol. 59:574–579.
ROSS, R. (1985). “Platelets, platelet-derived growth factor, growth control and their interactions with the vascular wall. ” J. Cardiov. Pharmacol. 7:S186–190.
SCHETTLER, F.G. and SANDWALD, R. (1969). “Vitamins.” In: Schettler, F.G. and Boyd, G.S. (eds.), Atherosclerosis. Elsevier, New York, pp. 891–899.
YARBRO, J.W., KENNEDY, B.J., and BARNUM, C.P. (1965). “Hydroxyurea inhibition of DNA synthesis in Ascites tumor.” Proc. Natl. Sci. USA 53:1033–1035.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ramos, K.S., McMahon, K.K., Alipui, C. et al. Modulation of DNA synthesis in aortic smooth muscle cells by dinitrotoluenes. Cell Biol Toxicol 7, 111–128 (1991). https://doi.org/10.1007/BF00122826
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00122826